Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
AVITA Medical, Inc. (NASDAQ: RCEL)
RCEL Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
43.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
2.20%
RCEL Stock Analysis
RCEL
PE Ratio:
RCEL
PEG Ratio:
Not Available
RCEL
Forward EPS Growth (12 month):
0.00%
RCEL
PS Ratio:
1.4
RCEL
PSG Ratio:
RCEL
Forward Revenue Growth (12 month):
49.60%
RCEL Articles
No data was found